Back to matchesWe found a matchYour institution may have rights to this item. Sign in to continue.TitleA phase II study of 2-methoxyestradiol (2ME2) NanoCrystal® dispersion (NCD) in patients with taxane-refractory, metastatic castrate-resistant prostate cancer (CRPC).AuthorsHarrison, Michael; Hahn, Noah; Pili, Roberto; Oh, William; Hammers, Hans; Sweeney, Christopher; Kim, KyungMann; Perlman, Scott; Arnott, Jamie; Sidor, Carolyn; Wilding, George; Liu, GlennPublicationInvestigational New Drugs, 2011, Vol 29, Issue 6, p1465ISSN0167-6997Publication typeArticleDOI10.1007/s10637-010-9455-x